VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30

VitaNova Life Sciences Corp

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026

$4.50+0.50 (+12.50%)

Close on Oct 19, 2026

Market cap: $37.52M
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Jul 31, 2026

VitaNova Life Sciences reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in VitaNova Life Sciences's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in VitaNova Life Sciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-3 reverse split on Mar 16, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is VNOV.

Revenue growth22.0% · median 254.0%

Gross margin26.9% · median 75.0%

Operating margin-2.7% · median -57.2%

Net margin-3.5% · median -159.7%

Company	Revenue	Growth
BHIC	$4.49M	+7.8%
BNKK	$3.61M	+851.3%
VNOV	$3.24M	+22.0%
BIOE	$2.91M	+416.6%
STEK	$2.40M	-38.6%
AHRO	$582.86K	+254.0%

Company

Exchange: OTC
Industry: Wholesale-Apparel, Piece Goods & Notions
Fiscal year ends: April 30
Employees: 7
Auditor: Simon & Edward, LLP
SEC CIK: 1699709

Advertisement
300 × 250